- Home
- Publications
- Publication Search
- Publication Details
Title
Protein Glycosylation as Biomarkers in Gynecologic Cancers
Authors
Keywords
-
Journal
Diagnostics
Volume 12, Issue 12, Pages 3177
Publisher
MDPI AG
Online
2022-12-16
DOI
10.3390/diagnostics12123177
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The evolving role of MUC16 (CA125) in the transformation of ovarian cells and the progression of neoplasia
- (2021) Panagiotis Giamougiannis et al. CARCINOGENESIS
- Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis
- (2021) Soichiro Kakimoto et al. Diagnostic Pathology
- Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2021) Usha Menon et al. LANCET
- Glycomic-Based Biomarkers for Ovarian Cancer: Advances and Challenges
- (2021) Francis Mugeni Wanyama et al. Diagnostics
- HE4 as a Biomarker for Endometrial Cancer
- (2021) Roya Behrouzi et al. Cancers
- Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors
- (2021) Hung Shen et al. Frontiers in Oncology
- High GLYPICAN-3 expression Characterizes a Biologically Distinct subset of ovarian clear cell carcinomas in Canadian patients: An Opportunity for targeted Therapy
- (2020) Katharina Wiedemeyer et al. HUMAN PATHOLOGY
- C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer
- (2020) Po-Chu Lee et al. ONCOGENE
- A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis
- (2020) Rohitesh Gupta et al. Cells
- GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M
- (2020) Chang Liu et al. Aging-US
- The Role of Glypicans in Cancer Progression and Therapy
- (2020) Nan Li et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis
- (2020) Eva Coll-de la Rubia et al. Journal of Clinical Medicine
- Serum CA19 ‐9, CA ‐125 and CEA as tumor markers for mucinous ovarian tumors
- (2020) Arb‐aroon Lertkhachonsuk et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- The role of biomarkers in endometrial cancer and hyperplasia: a literature review
- (2019) Suzanna Hutt et al. ACTA ONCOLOGICA
- Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
- (2019) Vincent Dochez et al. Journal of Ovarian Research
- Glycosylation in health and disease
- (2019) Colin Reily et al. Nature Reviews Nephrology
- High expression of MUC20 drives tumorigenesis and predicts poor survival in endometrial cancer
- (2019) Fei Zheng et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Prognostic Role of Squamous Cell Carcinoma Antigen in Cervical Cancer: A Meta-analysis
- (2019) Zhenhua Liu et al. DISEASE MARKERS
- The biology of mucus: Composition, synthesis and organization
- (2018) Rama Bansil et al. ADVANCED DRUG DELIVERY REVIEWS
- Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Emerging Biomarker for Skin Inflammatory Diseases
- (2018) Kenji Izuhara et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Screening for Ovarian Cancer
- (2018) Jillian T. Henderson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway
- (2018) Syue-Ting Chen et al. ONCOGENE
- Prognostic values of HE4 expression in patients with cancer: a meta-analysis
- (2018) Cong Dai et al. Cancer Management and Research
- Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer
- (2017) Satoko Matsuzaki et al. INTERNATIONAL JOURNAL OF CANCER
- Altered expression of different GalNAc-transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer
- (2017) Razan Sheta et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- N-acetylglucosaminyltransferase IVa promotes invasion of choriocarcinoma
- (2017) Kimihiro Nishino et al. ONCOLOGY REPORTS
- GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity
- (2017) Tzu-Chi Lin et al. Oncotarget
- MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β1 pathway
- (2016) Chi-Hau Chen et al. GYNECOLOGIC ONCOLOGY
- Endometrial cancer
- (2016) Philippe Morice et al. LANCET
- Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer
- (2016) Jing Bian et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection
- (2016) Zhi Li et al. Oncotarget
- MUC1 stimulates EGFR expression and function in endometrial cancer
- (2016) Brian J. Engel et al. Oncotarget
- N-acetylgalactosaminyltransferases in cancer
- (2016) Muhammad Ramzan Manwar Hussain et al. Oncotarget
- The Diagnostic Value of Transvaginal Sonograph (TVS), Color Doppler, and Serum Tumor Marker CA125, CEA, and AFP in Ovarian Cancer
- (2015) Fang Zhang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Cervical cancer: Biomarkers for diagnosis and treatment
- (2015) Subramanyam Dasari et al. CLINICA CHIMICA ACTA
- Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway
- (2015) Chih-Hsing Chou et al. Oncotarget
- Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics
- (2015) Alan Kirwan et al. Biomed Research International
- C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2
- (2015) Ji-Shiang Hung et al. Oncotarget
- Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation
- (2015) Zhi-Qiang Wang et al. Oncotarget
- MUC16: molecular analysis and its functional implications in benign and malignant conditions
- (2014) Dhanya Haridas et al. FASEB JOURNAL
- The Role of HE4 in Ovarian Cancer Follow-up
- (2014) Elisa Piovano et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) J. A. Ledermann et al. ANNALS OF ONCOLOGY
- The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
- (2013) Junli Deng et al. CANCER AND METASTASIS REVIEWS
- An Antibody-Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity against a Broad Range of Solid Tumors
- (2013) E. C. W. Breij et al. CANCER RESEARCH
- Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study
- (2013) Paul Sabbatini et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review
- (2013) Simona Ferraro et al. JOURNAL OF CLINICAL PATHOLOGY
- The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13
- (2013) RANRAN WANG et al. ONCOLOGY REPORTS
- High MUC2 Expression in Ovarian Cancer Is Inversely Associated with the M1/M2 Ratio of Tumor-Associated Macrophages and Patient Survival Time
- (2013) Yi-feng He et al. PLoS One
- Tn and sialyl-Tn antigens, aberrantO-glycomics as human disease markers
- (2013) Tongzhong Ju et al. Proteomics Clinical Applications
- Is serum human epididymis protein 4 ready for prime time?
- (2013) Simona Ferraro et al. ANNALS OF CLINICAL BIOCHEMISTRY
- High expression of N-acetylglucosaminyltransferase IVa promotes invasion of choriocarcinoma
- (2012) K Niimi et al. BRITISH JOURNAL OF CANCER
- MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR–STAT3 pathway in endometrial cancer
- (2012) Chi-Hau Chen et al. GYNECOLOGIC ONCOLOGY
- A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours
- (2012) Joseph T Rabban et al. HISTOPATHOLOGY
- Expression of GALNT2 in human extravillous trophoblasts and its suppressive role in trophoblast invasion
- (2012) W.-C. Liao et al. PLACENTA
- Expression of Tissue factor in Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix: Implications for immunotherapy with hI-con1, a factor VII-IgGFcchimeric protein targeting tissue factor
- (2011) Emiliano Cocco et al. BMC CANCER
- Mucin Glycosylating Enzyme GALNT2 Regulates the Malignant Character of Hepatocellular Carcinoma by Modifying the EGF Receptor
- (2011) Y.-M. Wu et al. CANCER RESEARCH
- Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family
- (2011) E. P. Bennett et al. GLYCOBIOLOGY
- Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer
- (2011) Rachel N Grisham et al. Immunotherapy
- MUC1 Expression Is Elevated in Severe Preeclamptic Placentas and Suppresses Trophoblast Cell Invasion via β1-Integrin Signaling
- (2011) Ming-Kwang Shyu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
- (2011) Richard G. Moore et al. OBSTETRICS AND GYNECOLOGY
- Critical Roles of Mucin 1 Glycosylation by Transactivated PolypeptideN-Acetylgalactosaminyltransferase 6 in Mammary Carcinogenesis
- (2010) Jae-Hyun Park et al. CANCER RESEARCH
- Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass
- (2010) Brian Nolen et al. GYNECOLOGIC ONCOLOGY
- Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype
- (2010) P. J. Kelly et al. JOURNAL OF CLINICAL PATHOLOGY
- Alterations in glycosylation as biomarkers for cancer detection
- (2010) C. A Reis et al. JOURNAL OF CLINICAL PATHOLOGY
- Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix
- (2010) Shinichi Togami et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Serum tumour markers in gynaecological cancers
- (2010) Pakhee Aggarwal et al. MATURITAS
- MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells
- (2010) M P Ponnusamy et al. ONCOGENE
- Expression of Glypican 3 in Ovarian and Extragonadal Germ Cell Tumors
- (2008) Debra L. Zynger et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer
- (2008) Ajay P Singh et al. LANCET ONCOLOGY
- Mining the plasma proteome for cancer biomarkers
- (2008) Samir M. Hanash et al. NATURE
- The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: A review of the literature
- (2007) Angiolo Gadducci et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now